Patent · US Active

Triazolo[4,5-D]pyrimidines

US10183946B2 · kind B2 · utility

4Cited by

4References

18Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Uwe Grether · Weil am Rhein, DE
Matthias Nettekoven · Weil am Rhein, DE
Mark Rogers-Evans · Bottmingen, CH
Sebastien Schmitt · Hagenthal-le-Bas, FR
Benjamin James Stenton · Cambridge, GB

Key dates

Filing date	Apr 4, 2017
Grant date	Jan 22, 2019
Priority date	—
Expiry date	Apr 4, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a compound of formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.